REFERENCES
- Rossi R, Godde A, Kleinebrand A, et al. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 1994;12:159–165.
- Brocklebank T, Cooper EH, Richmond K Sodium dodecyl suphate polyacrylamide gel electrophore-sis patterns of proteinuria in various renal diseases of childhood. Pediatr NephroL 1991;5:371–375.
- Boesken OH. SDS-PAGE: Gel Electrophoresis of Urinary Proteins. New York: de Gruyter; 1981.
- Weber WH. Urinary proteins analysis. J Chromatogr. 1988;429:315–344.
- Kierdorf H, Melzer H, Mann H, Sieberth HG. Differentation of proteins in polyacylamide gels by a modification of silver staining for the Phast System and a laserdensitometer. Electrophoresis. 1993; 14:820–822.
- Ashraf MS, Brady J, Breatnach F, Deasy PF, O'Meara A. Ifosfamide nephrotoxicity in paediatric cancer patients. Eur. J Pediatr. 1994;153:90–94.
- Boddy AV, English M, Pearson AD, Idle JR, Skinner R. Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics [see comments]. Eurf Cancer. 1996;7:1179–1184.
- Berns JS, Haghighat A, Staddon A, et al. Severe, irreversible renal failure after ifosfamide treatment: a clinicopathologic report of two patients. Cancer. 1995;76:497–500.
- Loebstein R, Koren G. Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics. 1998;101.
- Skinner R, Sharkey IM, Pearson AD, Craft AW. Ifosfamide, mesna, and nephrotoxicity in children. J Clin OncoL 1993;11:173–190.
- Skinner R, Pearson AD, English MW, et al. Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer. 1998;77:1677–1682.
- Shore R, Greenberg M, Geary D, Koren G. Iphosphamide-induced nephrotoxicity in children. Pediatr Nephrol. 1992;6:162–165.
- Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. The influence of age on nephrotoxicity following chemotherapy in children. BrJ Cancer Suppl. 1992;18:530–535.
- Rossi R, Danzebrink S, Hillebrand D, Linnenburger K, Ullrich K, Jurgens H. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol. 1994;22:27–32.
- Friedlaender MM, Haviv YS, Rosenmann E, Peylan-Ramu N. End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy. Am J Nephrol. 1998;18:131–133.
- Ashraf MS, Skinner R, English MW, Craft AW, Pearson AD. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child. Med Pediatr Oncol 1997;28:62–64.
- Brock PR, Koliouskas DE, Barratt M, Yeomans E, Pritchard J. Partial reversibility of cisplatin nephro-toxicity. J Pediatr. 1991;118:531–534.